Open AccessInferiority of IL-2 alone versus IL-2 with HAART in maintaining CD4 T cell counts during HAART interruption: a randomized controlled trial
Author(s) -
Brian Porter,
Kara B. Anthony,
Jean Shen,
Barbara Hahn,
Chris Keh,
Frank Maldarelli,
William C. Blackwelder,
H. Clifford Lane,
Joseph A. Kovacs,
Richard T. Davey,
Irini Sereti
Publication year - 2009
Publication title -
aids
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.195
H-Index - 216
eISSN - 1473-5571
pISSN - 0269-9370
DOI - 10.1097/qad.0b013e32831cc114
Subject(s) - medicine , confidence interval , gastroenterology , viral load , randomized controlled trial , immunology , prospective cohort study , aldesleukin , immune system , human immunodeficiency virus (hiv) , surgery , t cell
To evaluate whether interleukin (IL)-2 in patients with chronic HIV infection can maintain CD4 T cell counts during 6 months of HAART interruption.